Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dilara Akhoundova

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Cancer Cell|September 2, 2022
Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the futureDilara Akhoundova, Mark A Rubin
Nature Medicine|January 10, 2024
The grand challenge of moving cancer whole-genome sequencing into the clinicDilara Akhoundova, Mark A Rubin
Cancer Research|February 16, 2026
Reversing-or Rewiring-Lineage Plasticity? Lessons from EZH2 Loss in Prostate CancerPhillip Thienger, Dilara Akhoundova, Mark A Rubin
Medical Oncology (Northwood, London, England)|April 26, 2017
Controversies in the multimodality management of locally advanced rectal cancerRobert Díaz Beveridge, Dilara Akhoundova, Gema Bruixola, et al.
Advances in Anatomic Pathology|November 27, 2023
DNA Damage Response and Mismatch Repair Gene Defects in Advanced and Metastatic Prostate CancerDilara Akhoundova, Paola Francica, Sven Rottenberg, et al.
Surgical Pathology Clinics|November 7, 2022
Molecular Genetics of Prostate Cancer and Role of Genomic TestingDilara Akhoundova, Felix Y Feng, Colin C Pritchard, et al.
Current Opinion in Oncology|June 17, 2020
Adjuvant chemotherapy in biliary tract cancer: state of the art and future perspectivesDilara Akhoundova Sanoyan, Mairéad G McNamara, Angela Lamarca, et al.
Case Reports in Oncology|February 29, 2020
Sequential Treatment of Metastatic Adenocarcinoma of the Pancreatic Duct with Liver Metastasis Following the NAPOLI-1 Study Protocol with nal-Irinotecan plus 5-FU in the Second LineDilara Akhoundova Sanoyan, Cäcilia S Reiner, Panagiota Papageorgiou, et al.
Acta Haematologica|March 6, 2024
Peeling Back the Layers: Recurrent Talquetamab Skin Toxicity after Supportive Stem Cell Boost in Multiple MyelomaAlexander D Heini, Vera Ulrike Bacher, Dilara Akhoundova, et al.
Case Reports in Oncology|November 6, 2023
Exceptional Response to Pembrolizumab in a Mismatch Repair-Deficient Aggressive Prostate Cancer with Somatic EPCAM, MSH2, and MSH6 Co-Deletion: A Case ReportDennis Hoch, Manuela Rabaglio, Tobias Grob, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Cancer Cell|September 2, 2022
Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the futureDilara Akhoundova, Mark A Rubin
Nature Medicine|January 10, 2024
The grand challenge of moving cancer whole-genome sequencing into the clinicDilara Akhoundova, Mark A Rubin
Cancer Research|February 16, 2026
Reversing-or Rewiring-Lineage Plasticity? Lessons from EZH2 Loss in Prostate CancerPhillip Thienger, Dilara Akhoundova, Mark A Rubin
Medical Oncology (Northwood, London, England)|April 26, 2017
Controversies in the multimodality management of locally advanced rectal cancerRobert Díaz Beveridge, Dilara Akhoundova, Gema Bruixola, et al.
Advances in Anatomic Pathology|November 27, 2023
DNA Damage Response and Mismatch Repair Gene Defects in Advanced and Metastatic Prostate CancerDilara Akhoundova, Paola Francica, Sven Rottenberg, et al.
Surgical Pathology Clinics|November 7, 2022
Molecular Genetics of Prostate Cancer and Role of Genomic TestingDilara Akhoundova, Felix Y Feng, Colin C Pritchard, et al.
Current Opinion in Oncology|June 17, 2020
Adjuvant chemotherapy in biliary tract cancer: state of the art and future perspectivesDilara Akhoundova Sanoyan, Mairéad G McNamara, Angela Lamarca, et al.
Case Reports in Oncology|February 29, 2020
Sequential Treatment of Metastatic Adenocarcinoma of the Pancreatic Duct with Liver Metastasis Following the NAPOLI-1 Study Protocol with nal-Irinotecan plus 5-FU in the Second LineDilara Akhoundova Sanoyan, Cäcilia S Reiner, Panagiota Papageorgiou, et al.
Acta Haematologica|March 6, 2024
Peeling Back the Layers: Recurrent Talquetamab Skin Toxicity after Supportive Stem Cell Boost in Multiple MyelomaAlexander D Heini, Vera Ulrike Bacher, Dilara Akhoundova, et al.
Case Reports in Oncology|November 6, 2023
Exceptional Response to Pembrolizumab in a Mismatch Repair-Deficient Aggressive Prostate Cancer with Somatic EPCAM, MSH2, and MSH6 Co-Deletion: A Case ReportDennis Hoch, Manuela Rabaglio, Tobias Grob, et al.
Pageof 5